Basics BioAge Labs, Inc. IPO Date: September 26, 2024 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $503.05M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.30% Avg Daily Range (30 D): $0.48 | 3.96% Avg Daily Range (90 D): $0.26 | 2.90% Institutional Daily Volume Avg Daily Volume: .35M Avg Daily Volume (30 D): .45M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 98 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 77 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $2.06M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.81M Avg Closing Trade (30 D): $2.16M Avg Closing Trade (90 D): $1.74M Avg Closing Volume: 236.69K     News Dec 13, 2025 @ 3:15 PM 2 Reasons I Wouldn't Touch BioAge Labs Stock With ... Source: Prosper Junior Bakiny Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries Nov 7, 2025 @ 2:00 PM BioAge Labs to Present at Jefferies Global Healthc... Source: Bioage Labs, Inc. Oct 26, 2025 @ 10:33 PM BioAge Labs Stock Just Soared. Does It Have More F... Source: Cory Renauer Aug 15, 2025 @ 1:00 PM BioAge Labs Announces First Participant Dosed in P... Source: Bioage Labs Financials   TTM Q3 2025 Q2 2025 Basic EPS $13.61 $-.56 $-.6 Diluted EPS $13.61 $-.56 $-.6 Revenue $ 5.92M $ 2.05M $ 2.41M Gross Profit $ $ $ Net Income / Loss $ -75.79M $ -20.17M $ -21.56M Operating Income / Loss $ -89.72M $ -23.14M $ -24.77M Cost of Revenue $ $ $ Net Cash Flow $ -118.97M $ -4.75M $ -37.11M PE Ratio 1.32